$APGH Balance Sheet | Understand Stock

$APGH

$0.04 +$0.00 (0.0%) Close

$APGH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
CURRENT ASSETS
Accounts receivable, net
Deposits paid
Other receivable, prepayment and deposits
Deposits paid, prepayment and other receivables
Deferred costs of revenue
Amount due from a related party
Amount due from corporate shareholder of a subsidiary
Cash and cash equivalents
Total current assets

NON-CURRENT ASSETS
Investment in other companies
Total non-current assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES
Due to a related party
Account payable
Other payables and accrued liabilities
Amount due to a corporate shareholder
Deferred revenue
Share subscription received in advance
Total current liabilities

TOTAL LIABILITIES
STOCKHOLDERS’ DEFICIT
Common stock, $0.0001 par value, 600,000,000 shares authorized, 92,562,343 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
TOTAL STOCKHOLDERS’ DEFICIT
NON-CONTROLLING INTEREST

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Comments